๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The treatment of combination chemotherapy-resistant Hodgkin disease with single-agent vinblastine

โœ Scribed by Robert D. Warren; Dr Richard A. Bender; Larry Norton; Robert C. Young


Publisher
John Wiley and Sons
Year
1978
Tongue
English
Weight
539 KB
Volume
4
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Treatment of pediatric Hodgkin's disease
โœ Samar Muwakkit; Fady Geara; Bassem Nabbout; Roula A. Farah; Nina S. Shabb; There ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 157 KB ๐Ÿ‘ 2 views

Optimal treatment for Hodgkin's disease during childhood is unknown. We report the treatment outcome of patients with Hodgkin's disease โ‰ค13 years of age seen at the American University of Beirut Medical Center (AUBMC) between 1980 and 1996. A retrospective review of the medical records of 24 childre

Results of Treatment of 18 Children With
โœ Ekert, H. ;Waters, K. D. ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 470 KB

Eighteen children with Hodgkin disease ( 16previously untreated; two relapsed) were treated with MOPP chemotherapy (nitrogen mustard, vincristine, prednisone, procarbazine) only. Ten had clinical stage I and II disease, four had stage Ill, and four had stage IV. In ten patients, the clinical stage w

Combination chemotherapy with mitomycin-
โœ Niell, Harvey B. ;Griffin, John P. ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 443 KB

The drug combination of mitomycin-C, cisplatin, and vinblastine was administered to 30 patients with stage III non-small-cell lung cancer. All patients had a performance status of 50% or greater, had evaluable disease, and had not received previous chemotherapy. The overall response rate was 37% wit